MENU
NSRX
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
Nasus Pharma (NSRX) Earnings Date & Reports
Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions... Show more
A.I. Advisor
published Earnings
NSRX is expected to report earnings to fall 77.78% to -11 cents per share on December 02
Q3'26
Est.
$-0.12
Q2'26
Missed
by $0.31
Q4'25
Beat
by $0.15
The last earnings report on August 17 showed earnings per share of -54 cents, missing the estimate of -23 cents. With 14.57K shares outstanding, the current market capitalization sits at 35.84M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry PharmaceuticalsMajor
Industry
N/A
Address
Yigal Alon 65
Phone
+972 35736632
Employees
N/A
Web
https://www.nasuspharma.com